Reference
John N, et al. Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 90: 1376-1378, No. 12, Dec 2019. Available from: URL: http://doi.org/10.1136/jnnp-2019-320687 - United Kingdom
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1784, 23 (2019). https://doi.org/10.1007/s40278-019-72742-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-72742-1